1 Ocak 2020 Dergi makalesi Açık Erişim

Ozgul ozdemir, Rabia Bilge; Ozdemir, Alper Tunga; Kirmaz, Cengiz; Ovali, Ercument; Olmez, Ercument; Kerem, Hakan; Evrenos, Mustafa Kursat; Deniz, Gunnur

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Mesenchymal Stem Cells: a Potential Treatment Approach for Refractory Chronic Spontaneous Urticaria</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">STEM CELL REVIEWS AND REPORTS</subfield>
  </datafield>
  <controlfield tag="001">11573</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">The etiopathogenesis of chronic spontaneous urticaria (CSU) is not fully elucidated, and almost 30-40% of patients are resistant to treatments; therefore, there is still a need for the development of new and effective treatments. This study aimed to develop experimental cellular therapy for CSU patients resistant to current treatment options. Autologous adipose tissue mesenchymal stem cells (MSC) were administered to 10 refractory CSU patients who were then followed up for six months. The efficacy of treatment was evaluated according to the weekly urticaria activity scores (UAS7) and drug use scores (DUS7). To observe the effect of treatment on immune cells, CD4(+) T cell subsets were analyzed by flow cytometry, and the serum IFN-gamma, TNF-alpha, IL2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17a, IL-21, IL-22, TGF-beta 1, PGE2, IDO and anti-Fc epsilon RI levels were measured using the Luminex and ELISA methods. The values obtained were compared with 10 control refractory CSU patients and five healthy controls. We found that the T cell subsets and inflammatory molecules were not affected by MSC treatment during the follow-up period. In control patients, a significant decrease was detected only at the Th2 subset, TGF-beta 1, PGE2, IDO and anti-Fc epsilon RI levels on the 14th day of treatment. The UAS7 and DUS7 values of the MSC-treated patients significantly decreased during the follow-up period, but in control patients, a significant but temporary decrease was seen. According to our findings, unlike conventional treatment, MSC therapy resulted in longer and more effective recovery. Our data indicate that MSCs may be an alternative and effective approach for treatment-resistant CSU patients.</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozdemir, Alper Tunga</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Manisa Celal Bayar Univ, Med Sch, Dept Allergy &amp; Clin Immunol, Manisa, Turkey</subfield>
    <subfield code="a">Kirmaz, Cengiz</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Acibadem Univ, Med Sch, Div Hematol, Dept Internal Med, Istanbul, Turkey</subfield>
    <subfield code="a">Ovali, Ercument</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Manisa Celal Bayar Univ, Med Sch, Dept Pharmacol, Manisa, Turkey</subfield>
    <subfield code="a">Olmez, Ercument</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Manisa Celal Bayar Univ, Med Sch, Dept Plast Surg, Manisa, Turkey</subfield>
    <subfield code="a">Kerem, Hakan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Manisa Celal Bayar Univ, Med Sch, Dept Plast Surg, Manisa, Turkey</subfield>
    <subfield code="a">Evrenos, Mustafa Kursat</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Immunol, Istanbul, Turkey</subfield>
    <subfield code="a">Deniz, Gunnur</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="b">article</subfield>
    <subfield code="a">publication</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Manisa City Hosp, Dept Allergy &amp; Clin Immunol, Manisa, Turkey</subfield>
    <subfield code="a">Ozgul ozdemir, Rabia Bilge</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-01-01</subfield>
  </datafield>
  <controlfield tag="005">20210315074156.0</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:11573</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:989daee22ac75c0227bbf7d92a6a77d1</subfield>
    <subfield code="s">240</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/11573/files/bib-2373bf22-20a2-4d83-a166-7234c337f2e9.txt</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
    <subfield code="a">Creative Commons Attribution</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1007/s12015-020-10059-w</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
</record>